Design, engineering, and delivery, of a custom talen cleaving NIH-CRM's episomal target sequence. Design and generation of episomal target sequence plasmid, cloning of each talaen unit in yeast…
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN268201200083C
- Awardee
-
Cellectis Bioresearch Inc. UEI RZHHE3DCZLF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $199,500
Award facts
- Contract value 100% obligated
- $199,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $199,500 |
About this award
This is a $199,500.00 firm fixed price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Cellectis Bioresearch Inc. The contract is for the design, engineering, and delivery of a custom TALEN (Transcription Activator-Like Effector Nuclease) cleaving sequence for the NHLBI's episomal target sequence. This includes designing and generating the episomal target sequence plasmid, cloning the TALEN units in a yeast expression vector, and measuring the cleavage rate using a yeast single strand annealing (SSA) assay. The contract does not have a set-aside designation and was awarded on September 26, 2012 with a completion date of December 27, 2013.
Description
Design, engineering, and delivery, of a custom talen cleaving NIH-CRM's episomal target sequence. Design and generation of episomal target sequence plasmid, cloning of each talaen unit in yeast expression vector, and measurement of cleavage rate by yeast single strand annealing (SSA) assay.
Quick answers
Who was awarded contract HHSN268201200083C?
HHSN268201200083C was awarded to Cellectis Bioresearch Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 26, 2012.
How much is contract HHSN268201200083C worth?
The government has obligated $199,500 on HHSN268201200083C.
Was contract HHSN268201200083C competed?
The extent of competition for HHSN268201200083C was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award